Target intelligence / Profile preview

Nudix hydrolase 9 pseudogene 1 (NUDT9P1)

Target
NUDT9P1
Molecular classification
Other (Pseudogene)
01

Overview

Nudix hydrolase 9 pseudogene 1 (NUDT9P1) is a human pseudogene classified as a member of the nudix hydrolase family of genes, but it does not produce a functional protein product. As a pseudogene, NUDT9P1 is considered a noncoding genomic element arising from duplication or retrotransposition of the functional NUDT9 gene or another nudix family member, which has lost coding potential through mutations. It is not associated with disease pathology, drug interactions, or therapeutic interventions in current biomedical literature[3][5]. The term "pseudogene" specifically means that the sequence resembles that of a functional gene but is nonfunctional (does not encode a protein)[5]. Therefore, NUDT9P1 is not considered a biological target such as a receptor, enzyme, transporter, or any other class relevant to therapeutic intervention. Entries about NUDT9P1 elsewhere (e.g., GeneCards, Ensembl) consistently describe it as a pseudogene and not as an active player in molecular cell biology, pathology, or pharmacology[3][5]. NUDT9P1 is a bona fide genomic locus but *not* a viable drug or disease target. There is nothing incorrect about the locus name or assignment, but it is important to note its limited biological and pharmacological significance.

Other names
MGC34007bA56M3.1C10orf98BA56M3.1[3][5]

Beyond the preview

Go deeper on Nudix hydrolase 9 pseudogene 1 (NUDT9P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nudix hydrolase 9 pseudogene 1 (NUDT9P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call